SAM
Sawgrass Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-13,705
| Closed | -$230K | – | 193 |
|
|
2023
Q4 | $230K | Sell |
13,705
-38
| -0.3% | -$639 | 0.03% | 185 |
|
|
2023
Q3 | $161K | Sell |
13,743
-2,601
| -16% | -$30.4K | 0.02% | 192 |
|
|
2023
Q2 | $220K | Sell |
16,344
-6,859
| -30% | -$92.2K | 0.03% | 171 |
|
|
2023
Q1 | $385K | Buy |
23,203
+417
| +2% | +$6.91K | 0.05% | 124 |
|
|
2022
Q4 | $424K | Buy |
22,786
+12,133
| +114% | +$226K | 0.06% | 118 |
|
|
2022
Q3 | $137K | Sell |
10,653
-4,535
| -30% | -$58.3K | 0.02% | 144 |
|
|
2022
Q2 | $106K | Sell |
15,188
-894
| -6% | -$6.24K | 0.01% | 151 |
|
|
2022
Q1 | $133K | Buy |
+16,082
| New | +$133K | 0.01% | 159 |
|
|
2021
Q4 | – | Sell |
-21,705
| Closed | -$115K | – | 204 |
|
|
2021
Q3 | $115K | Sell |
21,705
-1,485
| -6% | -$7.87K | 0.01% | 164 |
|
|
2021
Q2 | $133K | Buy |
+23,190
| New | +$133K | 0.01% | 177 |
|
|
2020
Q3 | – | Sell |
-10,870
| Closed | -$50K | – | 155 |
|
|
2020
Q2 | $50K | Buy |
+10,870
| New | +$50K | ﹤0.01% | 147 |
|